Afimmune Initiates Epeleuton Phase IIb TRIAGE Study in Patients With High Triglycerides and Type 2 Diabetes
Data from Phase IIa show potent effect of Epeleuton on Triglyceride and HbA1C levelsAfimmune, a clinical stage drug discovery company...
Epeleuton
